...
首页> 外文期刊>Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation >HLA-matched sibling hematopoietic stem cell transplantation for fanconi anemia: comparison of irradiation and nonirradiation containing conditioning regimens.
【24h】

HLA-matched sibling hematopoietic stem cell transplantation for fanconi anemia: comparison of irradiation and nonirradiation containing conditioning regimens.

机译:HLA匹配的同种异体造血干细胞移植治疗范可尼贫血:照射和不照射条件疗法的比较。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Related to the underlying DNA repair defect that is the hallmark of Fanconi anemia (FA), preparatory regimen-related toxicities have been obstacles to hematopoietic cell transplantation (HCT). In an attempt to decrease the risk and severity of regimen-related toxicities, nonirradiation regimens have been explored. The aim of this study is to compare outcomes after irradiation and nonirradiation regimens in 148 FA patients and identify risk factors impacting upon HCT outcomes. Hematopoietic recovery, acute and chronic graft-versus-host disease (aGVHD, GVHD), and mortality were similar after irradiation and nonirradiation regimens. In both groups of recipients aged >10 years, prior use of androgens and cytomegalovirus seropositivity in either the donor or recipient were associated with higher mortality. With median follow-ups >5 years, the 5-year probability of overall survival, adjusted for factors impacting overall mortality was 78% and 81% after irradiation and nonirradiation regimens, P = .61. In view of the high risk of cancer and other radiation-related effects on growth and development, these results support the use of nonirradiation preparatory regimens. As the peak time for developing solid tumors after HCT is 8 to 9 years, longer follow-up is required before definitive statements can be made regarding the impact of nonirradiation regimens on cancer risk.
机译:与潜在的DNA修复缺陷有关,这是Fanconi贫血(FA)的标志,与治疗方案相关的毒性一直是造血细胞移植(HCT)的障碍。为了降低与方案有关的毒性的风险和严重性,已经探索了非辐照方案。这项研究的目的是比较148例FA患者的放疗和不放疗方案后的结局,并确定影响HCT结局的危险因素。放疗和不放疗方案后,造血恢复,急性和慢性移植物抗宿主病(aGVHD,GVHD)和死亡率相似。在年龄大于10岁的两组接受者中,在供者或接受者中既往使用雄激素和巨细胞病毒血清阳性与更高的死亡率相关。中位随访时间> 5年,经放疗和不放疗方案校正后影响总死亡率的因素后,5年总生存率分别为78%和81%,P = 0.61。鉴于癌症和其他辐射相关影响生长和发育的高风险,这些结果支持使用非辐射预备方案。由于HCT发生实体瘤的高峰时间为8到9年,因此需要更长的随访时间才能确定非照射方案对癌症风险的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号